The modulation of colorectal cancer (CRC) by oestrogen receptors has emerged as a field of great promise, drawing attention to the differential roles of receptor subtypes in tumour initiation, ...
The company seeks to leverage the benefits of estrogen signaling to prevent age-related diseases and improve the “healthspan" ...
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common ...
The hormone contributes to increased tumor growth in estrogen receptor-negative breast cancer tumors and in melanoma tumors, which do not rely on estrogen receptors for tumor growth. Conversely, ...
Basel, 9 March 2026 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today results from the phase III persevERA Breast Cancer study evaluating investigational giredestrant in combination with ...
Chronic kidney disease (CKD) affects more than 10% of the global population and is expected to become the fifth leading cause of death worldwide within the next two decades. Perhaps surprisingly, ...
CEO Sean Bohen outlined the company’s focus on advancing endocrine therapies for ER-positive, HER2-negative breast cancer during a discussion at Citi’s Virtual Oncology Summit, highlighting two ongoin ...
A growing understanding of how “reproductive” hormones sculpt the brain could transform the management of neurological conditions. Credit...Yuko Shimizu Supported by By Rachel E. Gross Estrogen is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results